🇮🇳IN
Sign In
SM

SMSPHARMA

NSE

SMS Pharmaceuticals Limited

₹514.15

+12.15(+2.42%)

Group Companies

Foreign Flows

sector level — not this stock
Healthcare sector+₹3 Crnet foreign buying
2026-09-16 to 2026-09-end

This is the flow into the whole Healthcare sector, not into SMSPHARMA. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.

Supply Chain

suppliers and customers in the graph

Relationship Network

directors, institutions, group entities

Macro Sensitivity

rates, currency, commodities

Revenue by Segment

Business Group

Geographic Exposure

revenue, imports, currency

Scenario analysis

stated assumptions, shown workings

SMSPHARMA exposure summary

SMS Pharmaceuticals Limited reports a single business segment, Manufacture of Active Pharmaceutical Ingredients(Bulk Drugs), Peptides and Intermediates. SMS Pharmaceuticals Limited is a constituent of 2 indices.

Index memberships2

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer